Bruker Corporation
BRKR | NASDAQ
$57.07
-$4.93 (-7.95%)
At close: Oct 30, 2026, 4:00 PM ET
$58.21
+$1.14 (+2.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 3.44B | 3.37B | 2.96B | 2.53B | 2.42B | 1.99B |
Cost of Revenue | 1.86B | 1.72B | 1.45B | 1.23B | 1.21B | 1.05B |
Gross Profit | 1.58B | 1.65B | 1.51B | 1.31B | 1.21B | 939.8M |
Operating Income | 236M | 253.1M | 436.9M | 432.7M | 413.3M | 248.3M |
Interest Income | 14.8M | 9.3M | 7.5M | 2.8M | 900K | 3.2M |
Pretax Income | 21M | 205.2M | 546.2M | 414.9M | 393.6M | 225.8M |
Net Income | -8.6M | 113.1M | 427.2M | 296.6M | 277.1M | 157.8M |
Selling & General & Admin | 946.5M | 893.8M | 729.4M | 607.4M | 562.3M | 477.8M |
Research & Development | 395.2M | 376.5M | 294.8M | 235.9M | 220.8M | 198M |
Other Expenses | n/a | 126.1M | 52.2M | 29.7M | 13.2M | 15.7M |
Operating Expenses | 1.34B | 1.4B | 1.08B | 873M | 796.3M | 691.5M |
Interest Expense | 60.3M | 47.9M | 16.4M | 16.1M | 14.3M | 14.4M |
Selling & Marketing Expenses | n/a | n/a | -600K | -2.4M | n/a | n/a |
Cost & Expenses | 3.2B | 3.11B | 2.53B | 2.1B | 2B | 1.74B |
Income Tax Expense | 29.3M | 91.4M | 117.7M | 116.4M | 113M | 64.4M |
Shares Outstanding (Basic) | 151.8M | 149M | 146.4M | 148.6M | 151.4M | 153.4M |
Shares Outstanding (Diluted) | 151.8M | 149.5M | 147.2M | 149.4M | 152.9M | 154.6M |
EPS (Basic) | -0.15 | 0.76 | 2.92 | 2 | 1.83 | 1.03 |
EPS (Diluted) | -0.15 | 0.76 | 2.90 | 1.99 | 1.81 | 1.02 |
EBITDA | 302.6M | 438.6M | 675.5M | 518.7M | 497.1M | 320.6M |
EBIT | 82.3M | 254.8M | 560.6M | 430M | 407.9M | 240.2M |
Depreciation & Amortization | 220.3M | 183.8M | 114.9M | 88.7M | 89.2M | 80.4M |
Add to Watchlist
Select watchlists to add or remove BRKR